Advertisement

Depression in Cancer Patients

  • Jimmie C. Holland*
  • Yesne Alici-Evcimen
Chapter
Part of the Cancer Drug Discovery and Development book series (CDD&D)

Abstract

Oncologists commonly encounter patients with depressive symptoms. It is important for the clinician to recognize and treat these symptoms in cancer patients, since they can occur for both physical and psychological reasons. This chapter describes assessment of depression, differentiating between types and causes of depressive disorders, and treatment interventions. Risk factors for suicide, assessment and management of suicide are also reviewed.

Key words:

Depression Cancer Suicide Psycho-oncology 

References

  1. 1.
    Bukberg J, Penman D, Holland JC. 1984; Depression in hospitalized cancer patients. Psychosom Med 46:199–212.PubMedGoogle Scholar
  2. 2.
    Massie MJ. 2004; Prevalence of depression in patients with cancer J of National Cancer Inst Monogr 32:57–71.CrossRefGoogle Scholar
  3. 3.
    McDaniel JS, Musselman DL, Porter MR, Reed DA, Nemeroff CB. 1995; Depression in patients with cancer: diagnosis, biology, and treatment. Arch Gen Psychiatry 52:89–99.PubMedCrossRefGoogle Scholar
  4. 4.
    Blazer DG, Kessler KC, McGonagle KA, Swartz MS.. 1994; The prevalence and distribution of major depression in a national community sample: The National Comorbidity Survey Am J Psychiatry 151:979–986.PubMedGoogle Scholar
  5. 5.
    Chochinov HM, Wilson KG, Enns M, Lander S. 1994; Prevalence of depression in the terminally ill: Effects of diagnostic criteria and symptom threshold judgments. Am J Psychiatry 151:537–540.PubMedGoogle Scholar
  6. 6.
    Coups EJ, Winell J, Holland JC. 2005:Depression in the context of cancer. In: Licinio J, Ma-Le Wong, eds. Biology of Depression: From Novel Insights to Therapeutic Strategies, Vol. 1. Wiley, Weinheim, Germany: 365–385.Google Scholar
  7. 7.
    Roth AJ, Holland JC. 1994; Treatment of depression in cancer patients. Prim Care Cancer 14:23–29.Google Scholar
  8. 8.
    Cohen-Cole SA, Brown FW, McDanile JS. 1993:Diagnostic assessment of depression in the medically ill. In: Stoudemire A, Fogel BS, eds. Psychiatric Care of the Medical Patient. Oxford University Press, New York: 53–70.Google Scholar
  9. 9.
    Spitzer RL, Endicott J, Robins E. 1978; Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 35:773–782.PubMedCrossRefGoogle Scholar
  10. 10.
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994.Google Scholar
  11. 11.
    Medical Letter. Drugs that cause psychiatric symptoms. Med Lett 1993;35:65–70.Google Scholar
  12. 12.
    Newport DJ, Nemeroff CB. 1998; Assessment and treatment of depression in the cancer patient. J Psychosom Res 45:215–237.PubMedCrossRefGoogle Scholar
  13. 13.
    Ebrahimi B, Tucker SL, Li D, et al. 2004; Cytokines in pancreatic carcinoma. Cancer 101:2727–2736.PubMedCrossRefGoogle Scholar
  14. 14.
    Lerner DM, Stoudemire A, Rosenstein DL. 2001:Cytokine-induced neuropsychiatric toxicity. In: Holland SM, ed. Cytokine Therapeutics in Infectious Diseases. Lippincott Williams & Wilkins, Philadelphia, PA: 323–332.Google Scholar
  15. 15.
    Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S,. et al. 2001; Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 344:961–966.PubMedCrossRefGoogle Scholar
  16. 16.
    Holland JH, Friedlander MM. 2006:Oncology. In: Blumenfield M, Strain JJ, eds. Psychosomatic Medicine. Lippincott Williams & Wilkins, Philadelphia, PA: 121–144.Google Scholar
  17. 17.
    Plumb MM, Holland JC. 1981; Comparative studies of psychological function in patients with advanced cancer – II. Interviewer-rated current and past psychological symptoms. Psychosom Med 43:243–254.PubMedGoogle Scholar
  18. 18.
    Spiegel D, Sand S, Koopman C. 1994; Pain and depression in patients with cancer. Cancer 74:2570–2578.PubMedCrossRefGoogle Scholar
  19. 19.
    Kathol RG, Mutgi A, Williams J, Clamon G, Noyes RJr.1990; Diagnosis of major depression in cancer patients according to four sets of criteria. Am J Psychiatry 147:1021–1024.PubMedGoogle Scholar
  20. 20.
    Schroevers MJ, Ranchor AV, Sanderman R. 2003; The role of social support and self-esteem in the presence and course of depressive symptoms: a comparison of cancer patients and individuals from the general population. Soc Sci Med 57:375–385.PubMedCrossRefGoogle Scholar
  21. 21.
    Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB. 1993; Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J Affect Disord 29:85–96.PubMedCrossRefGoogle Scholar
  22. 22.
    DeFlorio ML, Massie MJ. 1995; Review of depression in cancer: gender differences. Depression 3:66–80.CrossRefGoogle Scholar
  23. 23.
    Bolund C. 1985; Suicide and cancer. II: Medical and care factors in suicide by cancer patients in Sweden. 1973–1976. J Psychosoc Oncol 3:17–30.CrossRefGoogle Scholar
  24. 24.
    Farberow NL, Ganzler S, Cuter F, Reynolds D. 1971; An eight-year survey of hospital suicides. Suicide Life Threat Behav 1:198–201.Google Scholar
  25. 25.
    Louhivuori KA, Hakama J. 1979; Risk of suicide among cancer patients. Am J Epidemiol 109:59–65.PubMedGoogle Scholar
  26. 26.
    Weisman AD. 1976.Coping behavior and suicide in cancer. In: Cullen JW, Fox BH, Ison RN, eds. Cancer: The Behavioral Dimensions. Raven press, New York:Google Scholar
  27. 27.
    Conwell Y, Caine ED. 1991; Rational suicide and the right to die: reliability and myth. N Engl J Med 325:1100.PubMedCrossRefGoogle Scholar
  28. 28.
    Chochinov HM, Wilson KG, Ennis M,. et al. 1995; Desire for death in the terminally ill. Am J Psychiatry 152:1185–1191.PubMedGoogle Scholar
  29. 29.
    Chochinov HM, Wilson KG, Ennis M, Lander S. 1998; Depression, hopelessness, and suicidal ideation in the terminally ill. Psychosomatics 39:336–370.CrossRefGoogle Scholar
  30. 30.
    Rosenfeld B, Krevo S, Breitbart W,. et al. 2000:Suicide, assisted suicide, and euthanasia in the terminally ill. In: Chochinov H, Breitbart W, eds. Handbook of Psychiatry in Palliative Medicine. Oxford University Press, New York, NY: 51–63.Google Scholar
  31. 31.
    Achte KA, Vanhkouen ML. 1971; Cancer and the psyche. Omega 2:46–56.Google Scholar
  32. 32.
    Breitbart W. 1993:Suicide risk and pain in cancer and AIDS patients. In: Chapman CR, Foley KM, eds. Current and Emerging Issues in Cancer Pain: Research and Practice. Raven press, New York, NY: 49–65.Google Scholar
  33. 33.
    Kendal WS. Suicide and cancer: a gender-comparative study. Ann Oncol 2006 Oct 19; epub ahead of print .Google Scholar
  34. 34.
    Schairer C, Brown LM, Chen BE,. et al. 2006; Suicide after breast cancer: an international population-based study of 723 810 women. J Natl Cancer Inst 98:1416–1419.PubMedCrossRefGoogle Scholar
  35. 35.
    Holland JC, Gooen-Piels J:2003:Psycho-oncology. In: Holland JC, Frei E, eds. Cancer Medicine, 6th ed. B.C. Decker Inc, Hamilton, Ontario: 1039–1053.Google Scholar
  36. 36.
    Hietanen P, Lonnqvist J. 1991; Cancer and suicide. Ann Oncol 2:19.PubMedGoogle Scholar
  37. 37.
    Breitbart W, Cohen K. 1998:Delirium. In: Holland JC, ed. Psycho-Oncology. Oxford University Press, New York, NY: 564–575.Google Scholar
  38. 38.
    Recklitis CJ, Lockwood RA, Rothwell MA, Diller LR. 2006; Suicidal ideation and attempts in adult survivors of childhood cancer. J Clin Oncol 24:3852–3857.PubMedCrossRefGoogle Scholar
  39. 39.
    Dubovsky SL. 1978; Averting suicide in terminally ill patients. Psychosomatics 19:113–115.PubMedGoogle Scholar
  40. 40.
    Potash M, Breitbart W. 2002; Affective disorders in advanced cancer. Hematol/Oncol Clin North Am 16:671–700.CrossRefGoogle Scholar
  41. 41.
    American Psychiatric Association. Practice Guidelines for the Treatment of Patients with Major Depressive Disorder, 2nd ed. Arlington, VA: American Psychiatric Publishing, Inc., 2000.Google Scholar
  42. 42.
    The National Comprehensive Cancer Network. Distress Management Clinical Practice Guidelines in Oncology, version 1.2007.Google Scholar
  43. 43.
    Frazer A, Benmansour S. 2002; Delayed pharmacological effects of antidepressants. Mol Psychiatry 7:(Suppl 1)S23–S28.PubMedCrossRefGoogle Scholar
  44. 44.
    Hemaryeck A, Belpaire FM. 2002; Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug–drug interactions: an update. Curr Drug Metab 3:13–37.CrossRefGoogle Scholar
  45. 45.
    Joshi N, Breitbart WS. 2003; Psychopharmacologic management during cancer treatment. Semin Clin Neuropsychiatry 8:241–252.PubMedGoogle Scholar
  46. 46.
    DeVane CL. 1998; Differential pharmacology of newer antidepressants. J Clin Psychiatry 59:(Suppl 20)85–93.PubMedGoogle Scholar
  47. 47.
    Burke WJ. 2002; Escitalopram. Expert Opin Investig Drugs 11:1477–1486.PubMedCrossRefGoogle Scholar
  48. 48.
    Masand PS, Gupta S. 1999; Selective serotonin-reuptake inhibitors: an update. Harv Rev Psychiatry 7:69–84.PubMedGoogle Scholar
  49. 49.
    Horst WD, Preskorn SH. 1998; Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion. J Affect Disord 51:237–254.PubMedCrossRefGoogle Scholar
  50. 50.
    Dugan SE, Fuller MA. 2004; Duloxetine: a dual reuptake inhibitor. Ann Pharmacother 38:2078–2085.PubMedCrossRefGoogle Scholar
  51. 51.
    Nutt DJ. 2002; Tolerability and safety aspects of mirtazaoine. Hum Psychopharmacol 17:(Suppl 1)S37–S41.PubMedCrossRefGoogle Scholar
  52. 52.
    DeMarchi R, Bansal V, Hung A,. et al. 2005; Review of awakening agents. Can J Neurol Sci 32:4–17.PubMedGoogle Scholar
  53. 53.
    Morrow GR, Shelke AR, Roscoe JA,. et al. 2005; Management of cancer-related fatigue. Cancer Invest 23:229–239.PubMedCrossRefGoogle Scholar
  54. 54.
    Robertson P , Jr.Hellrigel ET. 2003; Clinical pharmacokinetic profile of Modafinil. Clin Pharmacokinet 42:123–137.PubMedCrossRefGoogle Scholar
  55. 55.
    Wisor JP, Eriksson KS. 2005; Dopaminergic–adrenergic interactions in the wake promoting mechanism of Modafinil. Neuroscience 132:1027–1034.PubMedCrossRefGoogle Scholar
  56. 56.
    Classen C, Butler LD, Koopman C, Miller E, DiMiceli S, Giese-Davis J, Fobair P, Carlson RW, Kraemer HC, Spiegel D. 2001; Supportive-expressive group therapy and distress in patient with metastatic cancer: a randomized clinical intervention trial. Arch Gen Psychiatry 58:494–501.PubMedCrossRefGoogle Scholar
  57. 57.
    Kissane DW, Bloch S, Smith GC. et al. 2003; Cognitive-existential group psychotherapy for women with primary breast cancer: a randomized controlled trial. Psychooncology 12:532–546.PubMedCrossRefGoogle Scholar
  58. 58.
    Beale MD, Kellner CH, Parsons PJ. 1997; ECT for the treatment of mood disorders in cancer patients. Convuls Ther 13:222–226.PubMedGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science + Business Media, LLC 2009

Authors and Affiliations

  • Jimmie C. Holland*
    • 1
  • Yesne Alici-Evcimen
    • 1
  1. 1.Department of Psychiatry and Behavioral SciencesMemorial Sloan-Kettering Cancer CenterNew YorkUSA

Personalised recommendations